CHGCY
Price:
$23.78
Market Cap:
$11.92T
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutic...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2012-08-03
Stock Exchange
PNK
Ticker
CHGCY
According to Chugai Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 30.88. This represents a change of 146.44% compared to the average of 12.53 of the last 4 quarters.
The mean historical PE Ratio of Chugai Pharmaceutical Co., Ltd. over the last ten years is 25.53. The current 30.88 PE Ratio has changed 11.99% with respect to the historical average. Over the past ten years (40 quarters), CHGCY's PE Ratio was at its highest in in the December 2017 quarter at 50.69. The PE Ratio was at its lowest in in the December 2022 quarter at 6.67.
Average
25.53
Median
26.32
Minimum
7.30
Maximum
43.26
Discovering the peaks and valleys of Chugai Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 82.60%
Maximum Annual PE Ratio = 43.26
Minimum Annual Increase = -53.60%
Minimum Annual PE Ratio = 7.30
Year | PE Ratio | Change |
---|---|---|
2023 | 13.32 | 82.60% |
2022 | 7.30 | -28.58% |
2021 | 10.22 | -51.39% |
2020 | 21.02 | 20.10% |
2019 | 17.50 | -53.60% |
2018 | 37.72 | -12.82% |
2017 | 43.26 | 22.43% |
2016 | 35.34 | -7.14% |
2015 | 38.05 | 20.39% |
2014 | 31.61 | 19.05% |
The current PE Ratio of Chugai Pharmaceutical Co., Ltd. (CHGCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
10.28
5-year avg
13.87
10-year avg
25.53
Chugai Pharmaceutical Co., Ltd.’s PE Ratio is greater than Scilex Holding Company (-0.98), greater than Merck & Co., Inc. (21.31), greater than Johnson & Johnson (26.16), less than Pfizer Inc. (36.93), less than Astellas Pharma Inc. (175.23), greater than Bristol-Myers Squibb Company PFD CONV 2 (-251.63), less than Otsuka Holdings Co., Ltd. (40.44), less than Novartis AG (0), greater than AstraZeneca PLC (12.63), less than GSK plc (34.38), greater than Roche Holding AG (23.17), greater than Bristol-Myers Squibb Company (13.64), greater than Horizon Therapeutics Public Limited Company (-15.49), less than Gilead Sciences, Inc. (88.04), less than Sanofi (106.39), greater than null (15.44),
Company | PE Ratio | Market cap |
---|---|---|
-0.98 | $185.04M | |
21.31 | $258.22B | |
26.16 | $380.98B | |
36.93 | $157.31B | |
175.23 | $19.92B | |
-251.63 | $113.09B | |
40.44 | $33.51B | |
0 | $216.23B | |
12.63 | $221.47B | |
34.38 | $75.40B | |
23.17 | $257.13B | |
13.64 | $112.46B | |
-15.49 | $0 | |
88.04 | $111.85B | |
106.39 | $132.76B | |
15.44 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chugai Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chugai Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Chugai Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
What is the highest PE Ratio for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
What is the 3-year average PE Ratio for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
What is the 5-year average PE Ratio for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
How does the current PE Ratio for Chugai Pharmaceutical Co., Ltd. (CHGCY) compare to its historical average?